What next? Expanding our view of city planning and global health, and implementing and monitoring evidence-informed policy.


Journal

The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665

Informations de publication

Date de publication:
06 2022
Historique:
received: 24 09 2021
revised: 16 12 2021
accepted: 04 02 2022
entrez: 13 5 2022
pubmed: 14 5 2022
medline: 18 5 2022
Statut: ppublish

Résumé

This Series on urban design, transport, and health aimed to facilitate development of a global system of health-related policy and spatial indicators to assess achievements and deficiencies in urban and transport policies and features. This final paper in the Series summarises key findings, considers what to do next, and outlines urgent key actions. Our study of 25 cities in 19 countries found that, despite many well intentioned policies, few cities had measurable standards and policy targets to achieve healthy and sustainable cities. Available standards and targets were often insufficient to promote health and wellbeing, and health-supportive urban design and transport features were often inadequate or inequitably distributed. City planning decisions affect human and planetary health and amplify city vulnerabilities, as the COVID-19 pandemic has highlighted. Hence, we offer an expanded framework of pathways through which city planning affects health, incorporating 11 integrated urban system policies and 11 integrated urban and transport interventions addressing current and emerging issues. Our call to action recommends widespread uptake and further development of our methods and open-source tools to create upstream policy and spatial indicators to benchmark and track progress; unmask spatial inequities; inform interventions and investments; and accelerate transitions to net zero, healthy, and sustainable cities.

Identifiants

pubmed: 35561726
pii: S2214-109X(22)00066-3
doi: 10.1016/S2214-109X(22)00066-3
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e919-e926

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : NIDDK NIH HHS
ID : P30 DK092950
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U48 DP006395
Pays : United States

Informations de copyright

This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.

Déclaration de conflit d'intérêts

Declaration of interests During the conduct of this study, BG-C reports Senior Principal Research Fellowship (GNT1107672) and grant support (number 1061404) from the Australian National Health and Medical Research Council (NHMRC); GB reports grants from The Public Good Projects; and JFS reports personal fees from SPARK programmes of Gopher Sport, a copyright on SPARK physical activity programmes with royalties paid by Gopher Sport, and serves on the board for Rails to Trails Conservancy outside the submitted work. All other authors declare no competing interests.

Auteurs

Billie Giles-Corti (B)

Healthy Liveable Cities Lab, Centre for Urban Research, RMIT University, Melbourne, VIC, Australia; Telethon Kids Institute, The University of Western Australia, Perth, WA, Australia. Electronic address: billie.giles-corti@rmit.edu.au.

Anne Vernez Moudon (AV)

Department of Urban Design and Planning, Urban Form Lab, University of Washington, Seattle, WA, USA.

Melanie Lowe (M)

Melbourne Centre for Cities, University of Melbourne, Melbourne, VIC, Australia.

Ester Cerin (E)

Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, VIC, Australia; School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, China.

Geoff Boeing (G)

Department of Urban Planning and Spatial Analysis, Sol Price School of Public Policy, University of Southern California, Los Angeles, CA, USA.

Howard Frumkin (H)

Center for Health and the Global Environment, University of Washington School of Public Health, Seattle, WA, USA.

Deborah Salvo (D)

Prevention Research Center, Brown School, Washington University in St Louis, St Louis, MO, USA.

Sarah Foster (S)

Healthy Liveable Cities Lab, Centre for Urban Research, RMIT University, Melbourne, VIC, Australia; School of Agriculture and Environment, The University of Western Australia, Perth, WA, Australia.

Alexandra Kleeman (A)

Healthy Liveable Cities Lab, Centre for Urban Research, RMIT University, Melbourne, VIC, Australia.

Sarah Bekessy (S)

ICON Science, Centre for Urban Research, RMIT University, Melbourne, VIC, Australia.

Thiago Hérick de Sá (TH)

Department of Environment, Climate Change and Health, World Health Organization, Geneva, Switzerland.

Mark Nieuwenhuijsen (M)

Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, VIC, Australia; Barcelona Institute for Global Health, Barcelona, Spain; Air Pollution and Urban Environment Programme, Pompeu Fabra University, Barcelona, Spain; Epidemiology and Public Health Network, CIBERSP, Madrid, Spain.

Carl Higgs (C)

Healthy Liveable Cities Lab, Centre for Urban Research, RMIT University, Melbourne, VIC, Australia.

Erica Hinckson (E)

Human Potential Centre, School of Sport and Recreation, Auckland University of Technology, Auckland, New Zealand.

Deepti Adlakha (D)

Department of Landscape Architecture and Environmental Planning, Natural Learning Initiative, College of Design, North Carolina State University, Raleigh, NC, USA.

Jonathan Arundel (J)

Healthy Liveable Cities Lab, Centre for Urban Research, RMIT University, Melbourne, VIC, Australia.

Shiqin Liu (S)

School of Public Policy and Urban Affairs, Northeastern University, Boston, MA, USA.

Adewale L Oyeyemi (AL)

Department of Physiotherapy, University of Maiduguri, Maiduguri, Nigeria.

Kornsupha Nitvimol (K)

Office of the Permanent Secretary for the Bangkok Metropolitan Administration, Bangkok, Thailand.

James F Sallis (JF)

Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, VIC, Australia; Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH